| __timestamp | Alpine Immune Sciences, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 7751000 |
| Thursday, January 1, 2015 | 6844000 | 10251000 |
| Friday, January 1, 2016 | 8586000 | 9575000 |
| Sunday, January 1, 2017 | 6079000 | 10912000 |
| Monday, January 1, 2018 | 8362000 | 11049000 |
| Tuesday, January 1, 2019 | 9467000 | 11646000 |
| Wednesday, January 1, 2020 | 10899000 | 13265000 |
| Friday, January 1, 2021 | 14560000 | 25805000 |
| Saturday, January 1, 2022 | 17968000 | 35182000 |
| Sunday, January 1, 2023 | 22222000 | 94999000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Viridian Therapeutics, Inc. from 2014 to 2023. Over this period, Alpine Immune Sciences saw a steady increase in SG&A expenses, starting at approximately $2.3 million in 2014 and reaching $22.2 million by 2023. This represents a nearly tenfold increase, highlighting their expanding operational scale.
Conversely, Viridian Therapeutics experienced a more dramatic rise. Their SG&A expenses surged from $7.8 million in 2014 to a staggering $94.9 million in 2023, marking an increase of over 1,100%. This sharp rise could indicate aggressive growth strategies or increased operational complexities. Such insights are invaluable for investors and stakeholders aiming to gauge the financial health and strategic direction of these companies.
Johnson & Johnson and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Merck & Co., Inc. or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Takeda Pharmaceutical Company Limited vs Viridian Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Evotec SE
SG&A Efficiency Analysis: Comparing Ultragenyx Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Vericel Corporation and Viridian Therapeutics, Inc.
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Ligand Pharmaceuticals Incorporated and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared